Led · Seed · Jul 2026

Energyminer develops the Energyfish, a floating, anchored strömungskraftwerk designed to harness natural river currents to produce continuous, emissions-free electricity without dams. The system operates nearly entirely underwater, is nearly silent, includes a proprietary fish-protection system, and can automatically sink to the riverbed during high water or ice while remaining operational. Generated power is intended for direct feed into local low-voltage grids to supply communities or industrial sites. The company highlights permanent digital monitoring of installations and positions the technology as a source of baseload-capable renewable energy. Energyminer is led by co-CEOs Dr. Richard Eckl and Dr. Georg Walder, with CTO Dr. Chantel Niebuhr, CMO Natalie Rojko, and CFO Rainer Schwarz. With the newly raised €2.1 million, the company plans to commercialize the Energyfish and transition it from development to broader market deployment.

Led · Equity · Jul 2026

Refined Diagnostics develops a Raman-laser based imaging diagnostic system that analyzes the molecular fingerprint of tissue to differentiate healthy and diseased tissue in minutes, aiming to enable intraoperative diagnoses. The company plans a clinical market entry in 2027 and is working toward CE-marking as an in vitro diagnostic (IVD). It was founded in 2019 as a spin-off of the University of Münster and already sells laser systems to research institutions, including for Raman microscopy and quantum technology applications. Management reports concrete purchase inquiries from clinics prior to official launch. Long-term product plans include adding AI-supported diagnostic aids to accelerate and improve tissue analysis and support personalized therapy decisions. Its business model pairs system sales with recurring revenue from leasing and service contracts.

Led · Equity · Jul 2026

Innok Robotics develops AMRs built on its HEROS robot platform and operated by its InnokCockpit autonomy software for real-world industrial sites. Its product lineup includes RAINOS, an autonomous watering robot used by municipalities and cemeteries; INDUROS, a transport robot that can pull up to 1.3 metric tons and operate on uneven terrain and in difficult weather; and the newly introduced INSPECTOS for inspection and surveillance. The company offers its systems via robots-as-a-service to reduce customer upfront capital expenditure and targets payback in under two years. Innok reported that order intake doubled in 2025 and that early INSPECTOS applications are already running in live operations for major customers. Its systems are deployed with medium-size and large industrial customers, including Mercedes, VW, BASF, Bosch, ABB, ZF and Volvo. The company is using the new funding to scale production, expand products and prepare for a planned fall 2026 IPO.

Led · Series A · Mar 2026

Founded in 2017 and headquartered in Cologne, Germany, Cellbox Solutions offers patented warm-chain technology that keeps cell samples at stable physiological conditions for up to 48 hours during transit. Its flagship Cellbox™ devices function as portable CO₂ incubators, allowing pharmaceutical and biotechnology companies, research institutions, and universities to ship living cells, organoids, and tissues without freezing. More than 300 units are already deployed worldwide, underscoring early commercial traction. The systems are certified and compliant with International Air Transport Association regulations, broadening their applicability to global air transport. Newly raised funds will be used to scale international production and sales operations and to expand use cases across cell and gene therapies, IVF, and other life-science workflows. The company has also strengthened its leadership by appointing Dr. Bernd Muehlenweg as Chief Business Officer and Chief Financial Officer to guide the next growth phase.

Led · Series A · Dec 2025

Founded in 2019, Munich-based Virtonomy provides a cloud platform that creates realistic digital patient twins using extensive datasets and multiphysics simulations. These virtual patients allow med-tech companies to test devices faster, run population analyses, and perform complete virtual studies, cutting development time by up to 40 % and saving millions in costs. The technology is already used by global leaders such as Medtronic, Johnson & Johnson, and Boston Scientific. With its recent Series A funding of more than €5 million, the company plans to deepen regulatory integration so virtual studies can be accepted in approval processes. The fresh capital will also support international scaling, a stronger global presence, and team expansion. Bayern Kapital has backed the company since its 2021 seed round, underscoring continued investor confidence in Virtonomy’s growth prospects.